← Back to Analyst Consensus 
RCKT Buy
ROCKET PHARMACEUTICALS, INC.
Current Price —
Implied Upside —
Analysts 20
30-Day Momentum
▲ 1 upgrades / ▼ 0 downgrades / 3 reiterations from 4 firms
Next Earnings
Nov 5, 2026 (10 days)
Rating Timeline
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Oct 8, 2026 | Goldman Sachs | upgrade | Sell → Neutral | — | 54% |
| Oct 7, 2026 | Leerink Partners | maintain | Market Perform → Market Perform | — | 51% |
| Oct 7, 2026 | Wedbush | reiterate | Outperform → Outperform | — | 58% |
| Oct 7, 2026 | Chardan Capital | maintain | Buy → Buy | — | 47% |
| Sep 16, 2026 | Wedbush | reiterate | Outperform → Outperform | — | 58% |
| Sep 16, 2026 | Needham | upgrade | Hold → Buy | — | 50% |
| Sep 15, 2026 | Chardan Capital | maintain | Buy → Buy | — | 47% |
| Sep 1, 2026 | Chardan Capital | maintain | Buy → Buy | — | 47% |
| Aug 11, 2026 | Wedbush | maintain | Outperform → Outperform | — | 58% |
| May 11, 2026 | Chardan Capital | maintain | Buy → Buy | — | 47% |
| Mar 30, 2026 | B of A Securities | maintain | Buy → Buy | — | 53% |
| Mar 27, 2026 | Chardan Capital | maintain | Buy → Buy | — | 47% |
| Mar 2, 2026 | Goldman Sachs | maintain | Sell → Sell | — | 54% |
| Feb 27, 2026 | Cantor Fitzgerald | maintain | Overweight → Overweight | $10 | 50% |
| Nov 18, 2025 | B of A Securities | maintain | Buy → Buy | $8 | 53% |
| Nov 18, 2025 | JP Morgan | downgrade | Overweight → Underweight | $263 | 54% |
| Oct 14, 2025 | Chardan Capital | maintain | Buy → Buy | $11 | 47% |
| Oct 3, 2025 | Leerink Partners | maintain | Market Perform → Market Perform | $7 | 51% |
| Aug 20, 2025 | B of A Securities | upgrade | Neutral → Buy | $10 | 53% |
| Aug 20, 2025 | Chardan Capital | maintain | Buy → Buy | $11 | 47% |
| Aug 11, 2025 | Chardan Capital | maintain | Buy → Buy | $11 | 47% |
| Aug 8, 2025 | Cantor Fitzgerald | maintain | Overweight → Overweight | $8 | 50% |
| Jul 25, 2025 | Canaccord Genuity | maintain | Buy → Buy | $10 | 48% |
| Jul 25, 2025 | B of A Securities | downgrade | Buy → Neutral | $4 | 53% |
| Jul 24, 2025 | Chardan Capital | maintain | Buy → Buy | $12 | 47% |
| Jul 24, 2025 | Needham | maintain | Hold → Hold | $0 | 50% |
| Jun 17, 2025 | UBS | maintain | Buy → Buy | $5 | 54% |
| Jun 3, 2025 | Canaccord Genuity | maintain | Buy → Buy | $11 | 48% |
| May 28, 2025 | B of A Securities | maintain | Buy → Buy | $9 | 53% |
| May 28, 2025 | BMO Capital | maintain | Outperform → Outperform | $8 | 53% |
| May 28, 2025 | Scotiabank | maintain | Sector Outperform → Sector Outperform | $19 | 55% |
| May 28, 2025 | Leerink Partners | downgrade | Outperform → Market Perform | $8 | 51% |
| May 28, 2025 | JP Morgan | downgrade | Overweight → Neutral | $7 | 54% |
| May 28, 2025 | Chardan Capital | maintain | Buy → Buy | $17 | 47% |
| May 28, 2025 | Jefferies | downgrade | Buy → Hold | $2.5 | 52% |
| May 27, 2025 | B of A Securities | maintain | Buy → Buy | $32 | 53% |
| May 27, 2025 | Needham | downgrade | Buy → Hold | $42 | 50% |
| May 16, 2025 | Cantor Fitzgerald | maintain | Overweight → Overweight | $30 | 50% |
| May 16, 2025 | Wedbush | reiterate | Outperform → Outperform | $32 | 58% |
| May 16, 2025 | Chardan Capital | maintain | Buy → Buy | $46 | 47% |
| May 12, 2025 | Scotiabank | maintain | Sector Outperform → Sector Outperform | $51 | 55% |
| May 12, 2025 | Canaccord Genuity | maintain | Buy → Buy | $34 | 48% |
| May 9, 2025 | Chardan Capital | maintain | Buy → Buy | $45 | 47% |
| May 9, 2025 | JP Morgan | maintain | Overweight → Overweight | $44 | 54% |
| May 9, 2025 | Goldman Sachs | maintain | Neutral → Neutral | $13 | 54% |
| Apr 9, 2025 | Needham | reiterate | Buy → Buy | $42 | 50% |
| Mar 12, 2025 | BMO Capital | initiate | — → Outperform | $50 | 53% |
| Mar 3, 2025 | Scotiabank | maintain | Sector Outperform → Sector Outperform | $52 | 55% |
| Mar 3, 2025 | Goldman Sachs | maintain | Neutral → Neutral | $15 | 54% |
| Mar 3, 2025 | Canaccord Genuity | maintain | Buy → Buy | $36 | 48% |
Price Target Trend
Jun 15, 2026 Oct 26, 2026
EPS Estimates
0q —
0y —
+1q —
+1y —
Cross-Platform Signals
No cross-platform signals in the last 90 days